Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Skin Diseases, Vascular
Description
Skin diseases affecting or involving the cutaneous blood vessels and generally manifested as inflammation, swelling, erythema, or necrosis in the affected area. MeSH
Hierarchy View
Subtype Terms (15)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
33 drugs (27 approved, 6 experimental)
Behcet Syndrome
39 drugs (33 approved, 6 experimental)
Cryoglobulinemia
9 approved drugs
Giant Cell Arteritis
30 drugs (26 approved, 4 experimental)
IgA Vasculitis
20 drugs (17 approved, 3 experimental)
Livedoid Vasculopathy
39 drugs (34 approved, 5 experimental)
Mucocutaneous Lymph Node Syndrome
17 approved drugs
Polyarteritis Nodosa
17 drugs (16 approved, 1 experimental)
Pyoderma Gangrenosum
15 drugs (9 approved, 6 experimental)
Sneddon Syndrome
1 approved drug
Takayasu Arteritis
23 drugs (21 approved, 2 experimental)
Urticaria
56 drugs (37 approved, 19 experimental)
Vasculitis, Leukocytoclastic, Cutaneous
10 drugs (9 approved, 1 experimental)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
